ATG5 and relapsing-remitting multiple sclerosis: We found that autophagy markers (ATG5 and ATG7) and mitophagy markers (Parkin and Optineurin) were significantly reduced in the serum of PPMS patients compared to control and relapsing‐remitting MS (RRMS) individuals.